SAM #36E79726R0033

Federal Procurement of Tacrolimus Capsules for VA, DoD, and Other Agencies

This opportunity involves a large-scale pharmaceutical procurement for federal healthcare agencies: - Government Buyer: - Department of Veterans Affairs (VA), National Acquisition Center, Enterprise Procurement Office AS7 - Also serving Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC) - Products Requested: - Tacrolimus Capsules in three strengths: - 0.5mg: 51,904 bottles (100 capsules per bottle) - 1mg: 142,788 bottles (100 capsules per bottle) - 5mg: 5,207 bottles (100 capsules per bottle) - Requirements: - Each offeror must supply products with a unique National Drug Code (NDC) and the exact name as it appears on the drug label - Only the successful offeror's label and NDC will be accepted; relabeling over another label is not permitted - Distribution will occur through VA and DoD Pharmaceutical Prime Vendor Programs - OEMs and Vendors: - No specific OEMs or vendors are named; the solicitation is open to all qualified manufacturers of Tacrolimus Capsules - Notable Details: - Contract term is one year with four pre-priced one-year option periods (up to five years total) - Estimated annual usage is specified for each strength, indicating a high-volume, multi-agency requirement

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0033 for an unrestricted procurement for Tacrolimus Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79726R0033 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 31, 2026, with a tentative closing date of September 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows:

REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 TACROLIMUS 0.5MG CAP 100 51,904 2 TACROLIMUS 1MG CAP 100 142,788 3 TACROLIMUS 5MG CAP 100 5,207

View original listing